Similarities between Tamoxifen and V. Craig Jordan
Tamoxifen and V. Craig Jordan have 5 things in common (in Unionpedia): American Cancer Society, Breast cancer, Osteoporosis, Raloxifene, Selective estrogen receptor modulator.
American Cancer Society
The American Cancer Society (ACS) is a nationwide voluntary health organization dedicated to eliminating cancer.
American Cancer Society and Tamoxifen · American Cancer Society and V. Craig Jordan ·
Breast cancer
Breast cancer is cancer that develops from breast tissue.
Breast cancer and Tamoxifen · Breast cancer and V. Craig Jordan ·
Osteoporosis
Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone.
Osteoporosis and Tamoxifen · Osteoporosis and V. Craig Jordan ·
Raloxifene
Raloxifene, developed by Eli Lilly in 1997 and sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.
Raloxifene and Tamoxifen · Raloxifene and V. Craig Jordan ·
Selective estrogen receptor modulator
Selective estrogen receptor modulators (SERMs) are a class of drugs that act on the estrogen receptor (ER).
Selective estrogen receptor modulator and Tamoxifen · Selective estrogen receptor modulator and V. Craig Jordan ·
The list above answers the following questions
- What Tamoxifen and V. Craig Jordan have in common
- What are the similarities between Tamoxifen and V. Craig Jordan
Tamoxifen and V. Craig Jordan Comparison
Tamoxifen has 111 relations, while V. Craig Jordan has 47. As they have in common 5, the Jaccard index is 3.16% = 5 / (111 + 47).
References
This article shows the relationship between Tamoxifen and V. Craig Jordan. To access each article from which the information was extracted, please visit: